Global Insomnia Market

Global Insomnia Market Size Insights Forecasts to 2035

• The Global Insomnia Market Size Was valued at USD 5.86 Billion in 2024
• The Global Insomnia Market Size is Expected to Grow at a CAGR of around 5.51% from 2025 to 2035
• The Worldwide Insomnia Market Size is Expected to Reach USD 10.57 Billion by 2035
• Asia-Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Decisions Advisors and Consulting, the Global Insomnia Market Size was worth around USD 5.86 Billion in 2024 and is predicted to grow to around USD 10.57 Billion by 2035 with a compound annual growth rate (CAGR) of 5.51% from 2025 to 2035. The market is expanding due to increasing modern lifestyle patterns and stress which combine with improvements in diagnostic technology and ongoing research for new treatments. The market is expanding because advanced healthcare systems and high sleep disorder rates and new treatment methods are being adopted.

 

Market Overview

The global insomnia market refers to the worldwide economic system that operates between the process of diagnosing insomnia and its subsequent treatment and ongoing patient management and monitoring of the sleep disorder which prevents people from falling asleep and remaining asleep and achieving full restorative sleep. The market encompasses all products which healthcare providers and patients and caregivers use to treat insomnia and its associated symptoms. Additionally, the market experiences positive growth because more people now suffer from stress and anxiety and mental health conditions. The American Psychiatric Association conducted its annual mental health study in 2024 which showed that US adults experienced increased anxiety levels. In 2024, 43% of adults reported feeling more anxious compared to 2023, an increase from 37% in 2023 and 32% in 2022. People today experience sleep problems because their work demands and digital technologies and social interactions create pressures. Both adults and adolescents develop insomnia because chronic stress causes hormonal imbalances and sleep-wake cycle disruptions. Sleep disorders frequently occur together with anxiety and depression, which results in higher requirements for medical treatments. More people seek mental health treatment today because public awareness about mental health has increased, which results in higher usage of sleep medication and therapy. Pharmaceutical companies are developing safer non-addictive drugs and cognitive behavioral treatments that focus on stress-related insomnia. The market keeps expanding because sleep health and psychological wellness become more interconnected as mental health issues increase around the world.

 

Report Coverage

This research report categorizes the insomnia market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the insomnia market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the insomnia market. 

 

Driving Factors

The Insomnia Therapeutics Market is currently experiencing a notable transformation, driven by a growing awareness of sleep disorders and their impact on overall health. The rising need for effective insomnia solutions results from people giving greater importance to their mental health needs. The therapeutic options have expanded to include multiple treatment methods which combine both medication-based and non-medication-based solutions. The development of sleep solutions, which use technology through sleep tracking devices and mobile applications, enables users to better follow their treatment plans. The insomnia market is experiencing a research and development growth because scientists want to discover what causes people to experience sleep problems. The scientific research will create new treatment methods which provide better solutions for insomnia. People now accept alternative therapies which include cognitive behavioral therapy and mindfulness practices, which shows that they prefer holistic methods for addressing sleep problems. The Insomnia Market stakeholders need to stay alert about two things which involve shifts in customer behavior and new scientific discoveries.

 

Restraining Factors

The first reason for limiting insomnia market growth exists because insomnia diagnosis and treatment costs are excessively high. The term 'sleeping disorder' includes multiple medical conditions which result in serious health consequences for patients. The condition of insomnia creates significant medical expenses together with financial obligations. Insomnia patients incur medical costs that exceed two times the expenses incurred by people who do not have this condition. The insomnia market will experience growth challenges because of the elevated expenses associated with diagnostic procedures and treatment solutions.

 

Market Segmentation

The insomnia market share is classified into therapy type and route of administration.

 

• The pharmacological therapy segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.           

Based on the therapy type, the insomnia market is divided into pharmacological therapy and non pharmacological therapy. Among these, the pharmacological therapy segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The treatment has become popular because it effectively helps patients who have sleep disorders to achieve immediate relief. Healthcare professionals recommend benzodiazepines and Z-drugs and specific antidepressants as the primary treatment option therefore these medications maintain their dominant position in the market. Patients seek alternative treatments because their dependency on these drugs creates worries about side effects.      

    

• The oral segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.     

Based on the route of administration, the insomnia market is divided into oral, parenteral and others. Among these, the oral segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Hospitals and specialty clinics and homecare settings use oral administration because it provides convenient and cost-efficient treatment for both acute and chronic insomnia cases. The segment benefits from extensive distribution networks and strong physician preference, particularly in outpatient care.   

 

Regional Segment Analysis of the Insomnia Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the insomnia market over the predicted timeframe.

North America is anticipated to hold the largest share of the insomnia market over the predicted timeframe. The North America regional market is driven by the increasing awareness and diagnosis of insomnia disorders, supported by robust healthcare infrastructure and diagnostic capabilities. The region's high prevalence of lifestyle-related factors such as stress, irregular work hours, and sedentary lifestyles, which are common in the population, lead to an increased occurrence of sleep disorders. The increasing elderly population in North America, who are more likely to develop insomnia, creates a greater demand for insomnia market products. The region experiences ongoing advancements in medical research and technology, which improve diagnostic precision and treatment success rates while driving the development of new therapeutic methods.

 

Asia-Pacific is expected to grow at a rapid CAGR in the insomnia market during the forecast period. The increasing academic demands which affect younger students and the extensive work responsibilities which burden adult workers create major problems which lead to more people developing insomnia. The public now understands mental health issues better than before which leads people to seek medical help through medical consultations and digital therapeutic tools and OTC supplements. Go Spiritual a major spiritual organization started its innovative mental health awareness initiative for India on World Mental Health Day which fell in October 2025.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the insomnia market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Takeda Pharmaceutical Company Limited
• Dr. Reddy’s Laboratories Ltd.
• Pfizer Inc.
• Endo International plc.
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Novartis AG
• Lupin Ltd.
• Cipla Inc.
• Aurobindo Pharma Ltd.
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Recent Development

 

• In May 2025, Eisai, a global pharmaceutical company, announced that its dual orexin receptor antagonist, lemborexant (brand name: Dayvigo), had received approval in China for the treatment of adults with insomnia characterized by difficulties with sleep onset and/or sleep maintenance. This launch expanded Eisai’s footprint in the Asian insomnia therapeutics market.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the insomnia market based on the below-mentioned segments: 

 

Global Insomnia Market, By Therapy Type

• Pharmacological therapy
• Non Pharmacological therapy

 

Global Insomnia Market, By Route of Administration

• Oral
• Parenteral
• Others

 

Global Insomnia Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  •  South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

 

Frequently Asked Questions (FAQ)

 

1. What is the CAGR of the insomnia market over the forecast period?

A: The global insomnia market is projected to expand at a CAGR of 5.51% during the forecast period.

 

2. What is the market size of the insomnia market?

A: The global insomnia market size is estimated to grow from USD 5.86 billion in 2024 to USD 10.57 billion by 2035, at a CAGR of 5.51% during the forecast period 2025-2035.   

 

3. Which region holds the largest share of the insomnia market?

A: North America is anticipated to hold the largest share of the insomnia market over the predicted timeframe.

 

4. Who are the top 10 companies operating in the global insomnia market?

A: Takeda Pharmaceutical Company Limited, Dr. Reddy’s Laboratories Ltd., Pfizer Inc., Endo International plc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Novartis AG, Lupin Ltd., Cipla Inc., Aurobindo Pharma Ltd., and Others.

 

5. What are the market trends in the insomnia market?

A: The insomnia market currently observes three main trends which include rising use of digital therapeutics together with increasing demand for non-drug treatments and growing public knowledge about sleep disorders and ongoing development of sleep medications throughout the world.